|
|
Article: Five Prime Therapeutics to Subscribe to a BioExpress Custom Suite from Gene Logic.
- Article from:
- Business Wire
- Article date:
- July 7, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
GAITHERSBURG, Md.--(BUSINESS WIRE)--July 7, 2003
Gene Logic Inc. (Nasdaq:GLGC) today announced that Five Prime Therapeutics, Inc. ("Five Prime"), a privately held biopharmaceutical company, has subscribed to a BioExpress(TM) Custom Suite. Five Prime will apply the Custom Suite as an added dimension to their proprietary Pharmanome(TM)-based therapeutics discovery efforts. Financial details of the multiyear subscription agreement were not disclosed.
Under the subscription agreement, Five Prime researchers will access a customized information product comprised of select sets of gene ...